Ji Hae Park
Papers
1
Total Citations
50
H-Index
1
About
Ji Hae Park is a clinical researcher whose work focuses on leveraging routine blood biomarkers to improve cancer risk stratification, particularly in prostate cancer. Her most-cited study, "Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer" (2015, 50 citations), demonstrates a practical, cost-effective approach to identifying patients who may safely avoid aggressive treatment. By showing that elevated neutrophil-to-lymphocyte ratios correlate with more aggressive disease, Park’s research offers clinicians a simple, accessible tool to complement traditional staging methods. This work contributes to the broader movement toward precision oncology, where inexpensive biomarkers help reduce overtreatment in low-risk patients. Park’s findings have been cited in subsequent studies exploring inflammatory markers in urologic cancers, underscoring their relevance to both clinical decision-making and future research. Her contributions highlight the potential of harnessing routine lab values to address critical challenges in cancer management.
Research Focus
Key Achievements
Top Papers
- 1